Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

WSE/KRK stock hub

WSE/KRK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WSE/KRKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

31.9B

Warsaw Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

WSE/KRK

In the news

Latest news · WSE/KRK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.6

P25 9.9P50 16.8P75 19.7

Trailing P/E18.8

P25 15.2P50 20.9P75 63

ROE17.5

P25 -39.9P50 -16.3P75 7.2

ROIC21.4

P25 -44.1P50 -13.4P75 4.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WSE/KRK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

EUR

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Slovenia
Country code	PL
Employees	11,667
Employees Change	359%
Employees Change Percent	3.17
Enterprise value	PLN 29.5B
Exchange	Warsaw Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	SI0031102120
Last refreshed	2026-05-10
Market cap	PLN 31.9B
Price	PLN 1,048
Price currency	PLN
Rev Per Employee	738,128.91x
Sector	Healthcare
Sic	2834
Symbol	wse/KRK
Website	https://www.krka.biz

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.33%
EV Earnings	17.36x
EV/EBIT	15.07x
EV/EBITDA	12.54x
EV/FCF	16.01x
EV/Sales	3.42x
FCF yield	5.78%
Forward P/E	18.64x
P/B ratio	3.18x
P/E ratio	18.77x
P/S ratio	3.71x
PE Ratio10 Y	11.59x
PE Ratio3 Y	12.59x
PE Ratio5 Y	11.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.69%
EBITDA Margin	27.05%
FCF margin	21.42%
Gross margin	57.96%
Gross Profit	PLN 5B
Gross Profit Growth	8.15%
Gross Profit Growth Q	8.59%
Gross Profit Growth3 Y	6.68%
Gross Profit Growth5 Y	5.36%
Net Income	PLN 1.7B
Net Income Growth	12.96%
Net Income Growth Q	5.85%
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Net Income Growth3 Y	3.54%
Net Income Growth5 Y	6.74%
Pretax Margin	24.3%
Profit Margin	19.76%
Profit Per Employee	PLN 145,829
Profitable Years	16
ROA	9.83
Roa5y	9.35
ROCE	18.21
ROE	17.49
Roe5y	16.57
ROIC	21.45
Roic5y	20.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.62%
Cagr1y	44.24%
Cagr3y	32.6%
Cagr5y	22.75%
Div CAGR10	11.59%
Div CAGR3	6.06%
Div CAGR5	8.78%
EPS Growth	13.91
EPS Growth Q	7.25
EPS Growth Years	2
EPS Growth3 Y	4.16
EPS Growth5 Y	7.35
FCF Growth	72.72%
FCF Growth Q	263.23%
FCF Growth3 Y	4.81%
FCF Growth5 Y	8.87%
OCF Growth	46.46%
OCF Growth Q	152.91%
OCF Growth10 Y	6.64%
OCF Growth3 Y	4.17%
OCF Growth5 Y	7.94%
Revenue Growth	6.89x
Revenue Growth Q	6.76x
Revenue Growth Quarters	8x
Revenue Growth Years	10x
Revenue Growth3 Y	5.92x
Revenue Growth5 Y	5.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	PLN 0.69
Assets	PLN 12.8B
Cash	PLN 2.6B
Current Assets	PLN 8.4B
Current Liabilities	PLN 2.1B
Debt	PLN 77.5M
Debt EBITDA	PLN 0.03
Debt Equity	PLN 0.01
Debt FCF	PLN 0.04
Equity	PLN 10B
Interest Coverage	66.04
Liabilities	PLN 2.8B
Long Term Assets	PLN 4.4B
Long Term Liabilities	PLN 686.7M
Net Cash	PLN 2.5B
Net Cash By Market Cap	PLN 7.75
Net Cash Growth	1.85%
Net Debt EBITDA	PLN -1.06
Net Debt Equity	PLN -0.25
Net Debt FCF	PLN -1.34
Tangible Book Value	PLN 9.5B
Tangible Book Value Per Share	PLN 314
WACC	6.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.96
Inventory Turnover	1.34
Net Working Capital	PLN 3.7B
Quick ratio	2.48
Working Capital	PLN 6.3B
Working Capital Turnover	PLN 6.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.85%
Dividend Growth	9.1%
Dividend Growth Years	8%
Dividend per share	PLN 35.03
Dividend Years	14
Dividend Yield	3.39%
Ex Div Date	2025-07-22
Last Dividend	PLN 35.03
Payout Frequency	Annual
Payout Ratio	62.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	551.67%
1Y total return	44.2%
200-day SMA	922.4
3Y total return	133.19%
50-day SMA	1,007.7
50-day SMA vs 200-day SMA	50over200
5Y total return	178.59%
All Time High	1,100
All Time High Change	-4.73%
All Time High Date	2026-02-16
All Time Low	106.6
All Time Low Change	882.66%
All Time Low Date	2013-04-30
ATR	23.84
Beta	0.42
Ch YTD	21.86
High	1,062
High52	1,100
High52 Date	2026-02-16
High52ch	-4.73%
Low	1,048
Low52	746
Low52 Date	2025-05-09
Low52ch	40.48%
Ma50ch	4%
Price vs 200-day SMA	13.62%
RSI	56.33
RSI Monthly	80.87
RSI Weekly	70.23
Sharpe ratio	1.38x
Sortino ratio	2.36
Total Return	4.23%
Tr YTD	21.86
Tr1m	5.22%
Tr1w	-0.19%
Tr3m	7.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PLN 2B
Operating Income Growth	8.89
Operating Income Growth Q	3.51
Operating Income Growth3 Y	6.86
Operating Income Growth5 Y	3.66
Operating margin	22.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,026,940%
Net Borrowing	-21,213,257.6
Shares Insiders	0.13%
Shares Institutions	26.36%
Shares Qo Q	-0.77%
Shares Yo Y	-0.85%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	PLN 1.8B
Average Volume	71.4x
Bv Per Share	327.8
CAPEX	PLN -385.4M
Ch10y	295.5
Ch1m	5.22
Ch1w	-0.19
Ch1y	38.26
Ch3m	7.82
Ch3y	100.8
Ch5y	116.1
Ch6m	17.75
Change	-0.19%
Change From Open	-0.19
Close	1,050
Days Gap	0
Depreciation Amortization	377,526,447.7
Dollar Volume	34,584
Earnings Date	2026-05-14
EBIT	PLN 2B
EBITDA	PLN 2.3B
EPS	PLN 55.74
F Score	6
FCF	PLN 1.8B
FCF EV Yield	6.25x
Financing CF	-1,384,964,242
Fiscal Year End	December
Founded	1,954
Goodwill	180,815,142.4
Graham Number	642.9877
Graham Upside	-38.65
Income Tax	PLN 389.3M
Investing CF	-807,140,197
Is Primary Listing	0
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Lynch Fair Value	PLN 376
Lynch Upside	-64.08
Ma150	937.7
Ma150ch	11.76%
Ma20	1,035.3
Ma20ch	1.23%
Net CF	12,337,309
Next Earnings Date	2026-05-14
Open	1,050
P FCF Ratio	17.31
P OCF Ratio	14.32
Payment Date	2025-07-24
Position In Range	0
Ppne	3,514,646,272.2
Price Date	2026-05-08
Price EBITDA	PLN 13.71
Ptbv Ratio	3.35
Relative Volume	0.46x
Revenue	8,611,749,959x
Tax By Revenue	4.52x
Tax Rate	18.61%
Tr6m	17.75%
Volume	33
Z Score	7.99

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

WSE/KRK dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.4%

$35.0 annual per share

Payout ratio

+62.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+8.8%

8 consecutive years of growth

Total shareholder yield

+4.2%

Next ex-dividend date: 2025-07-22

Performance

WSE/KRK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns WSE/KRK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.4%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

WSE/KRK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.3

Neutral momentum band

Price vs 200-day MA

+13.6%

50/200-day relationship not available

Beta (5Y)

0.42

Less volatile than the market

Sharpe ratio

1.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WSE/KRK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/KRK stock rating?

wse/KRK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/KRK analysis?

The full report lives at /stocks/wse/KRK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/KRK?

The latest report frames wse/KRK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/KRK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.